{"cardiac failure": 5.55, "condition aggravated": 4.12, "cyanosis": 8.71, "disease progression": 4.89, "drug interaction": 5.3, "fluid retention": 7.97, "general physical health deterioration": 3.49, "off label use": 2.33, "oxygen saturation decreased": 10.71, "product use in unapproved indication": 3.47, "product use issue": 6.29, "pulmonary arterial hypertension": 46.98, "pulmonary hypertension": 33.08, "pulmonary oedema": 10.62, "right ventricular failure": 92.69}